Virbac S.A. (VRBCF)
Virbac S.A. operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Carros, PA, FR. The stock last traded at $383.25, up 0.00% on the session, giving a market capitalisation of $3.21B. On trailing twelve-month figures it carries a trailing P/E of 18.55, a net margin of 10.3%. Its beta of 0.78 implies it has historically moved less than the broad market.
Virbac S.A. is a leading global animal health company that develops, produces, and distributes a comprehensive array of products and services designed for both domestic pets and livestock. The company maintains a significant international presence, operating across numerous regions including France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Its extensive portfolio encompasses solutions for disease prevention (such as vaccines), oral hygiene, reproductive health, dermatological conditions, parasite control, and diagnostics. Additionally, Virbac supplies various veterinary pharmaceuticals, including antibiotics, specialized medications for anesthesia, geriatric care, and behavioral issues, as well as injectable micronutrients and aquaculture products. The company also offers animal nutrition products (pet food) and electronic identification systems. Virbac primarily serves the needs of veterinarians, farmers, and individual pet owners. Established in 1968, the company is headquartered in Carros, France.
Virbac S.A. is most often compared with the following Healthcare names: